We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0R0T market cap is 142.09B. The company's latest EPS is USD 12.5510 and P/E is 20.93.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.36B | 25.42B | 25.98B | 26.32B | 28.19B |
| Operating Income | 9.67B | 9.14B | 7.64B | 9.57B | 9.35B |
| Net Income | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.71B | 62.95B | 61.17B | 65.12B | 97.15B |
| Total Liabilities | 50.03B | 53.54B | 54.47B | 61.46B | 90.92B |
| Total Equity | 9.67B | 9.41B | 6.7B | 3.66B | 6.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.15B | 10.5B | 9.26B | 9.72B | 8.47B |
| Investing | 5.71B | -5.4B | 733M | -6.04B | -26.2B |
| Financing | -15.77B | -4.87B | -8.27B | -4.04B | 21.05B |
| Market Cap | 142.09B |
| Price to Earnings Ratio | 20.93 |
| Price to Sales Ratio | 4.99 |
| Price to Cash Ratio | 12.85 |
| Price to Book Ratio | 22.56 |
| Dividend Yield | - |
| Shares Outstanding | 535.18M |
| Average Volume (1 week) | 2.91k |
| Average Volume (1 Month) | 2.47k |
| 52 Week Change | 7.71% |
| 52 Week High | 321.50 |
| 52 Week Low | 214.75 |
| Spread (Intraday) | 14.5 (5.36%) |
| Company Name | Amgen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
